ROBO2 and myelodysplastic syndrome: Additionally, using whole-exome and targeted sequencing in 209 patients with myelodysplastic syndrome (MDS) found ROBO1 and ROBO2 mutations in 26 (12.4%) patients (Xu et al. 2015).